Predictive QSAR models development and validation for human ether-a-go-go related gene (hERG) blockers using newer tools

被引:10
|
作者
Hari Narayana Moorthy, N. S. [1 ]
Ramos, Maria J. [1 ]
Fernandes, Pedro A. [1 ]
机构
[1] Univ Porto, REQUIMTE, Dept Quim & Bioquim, Fac Ciencias, P-4169007 Oporto, Portugal
关键词
hERG; Mahalanobis distances; pharmacophore; QSAR; vsurf_; STRUCTURAL-ANALYSIS; POTASSIUM CHANNEL; INHIBITORY-ACTIVITY; DRUG-BINDING; CLASSIFICATION; DERIVATIVES; STATE;
D O I
10.3109/14756366.2013.779264
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In the present computational analysis, pharmacophore-based active conformer selection method was used to derive active conformers for the physicochemical descriptors calculation. The significant regression models were validated using different validation methods, which provided significant Q(2) values. The distance-based approaches were also used to analyze the discriminant property of the molecules contributed in the models. The Mahalanobis distance (MD) values obtained from these studies revealed that the compounds with very high and very low acting human ether-a-go-go-related gene blockers possessed high MD values, while the predicted activity of those compounds exhibited less residual errors. The results obtained in the studies suggest that the distance-based approaches can be used to validate the quantitative structure-activity relationship models significantly. The descriptors contributed in the models explain that the flexibility of the bonds connected to the aromatic rings or non-polar region of the molecules make pi-pi interaction with the aromatic residues of the protein.
引用
下载
收藏
页码:317 / 324
页数:8
相关论文
共 50 条
  • [1] Blockade of human ether-a-go-go related gene (HERG) channels by quinidine.
    Congrong, L
    Cvetanovic, I
    Ranade, V
    Somberg, JC
    JOURNAL OF INVESTIGATIVE MEDICINE, 2004, 52 (02) : S347 - S347
  • [2] Activation of human ether-a-go-go related gene (hERG) potassium channels by small molecules
    Zhou, Ping-zheng
    Babcock, Joseph
    Liu, Lian-qing
    Li, Min
    Gao, Zhao-bing
    ACTA PHARMACOLOGICA SINICA, 2011, 32 (06) : 781 - 788
  • [3] Activation of human ether-a-go-go related gene (hERG) potassium channels by small molecules
    Ping-zheng Zhou
    Joseph Babcock
    Lian-qing Liu
    Min Li
    Zhao-bing Gao
    Acta Pharmacologica Sinica, 2011, 32 : 781 - 788
  • [4] High Yield Expression of the Human Ether-a-Go-Go Related Gene (HERG) in Saccharomyces Cerevisiae
    Molbaek, Karen
    Scharff-Poulsen, Peter
    Klaerke, Dan A.
    Pedersen, Per Amstrup
    BIOPHYSICAL JOURNAL, 2014, 106 (02) : 137A - 137A
  • [5] Human ether-a-go-go related gene (hERG) K+ channels: Function and dysfunction
    Perrin, Mark J.
    Subbiah, Rajesh N.
    Vandenberg, Jamie I.
    Hill, Adam P.
    PROGRESS IN BIOPHYSICS & MOLECULAR BIOLOGY, 2008, 98 (2-3): : 137 - 148
  • [6] Effects of phosphodiesterase (PDE) inhibitors on human ether-a-go-go related gene (hERG) channel activity
    Yunomae, Kiyokazu
    Ichisaki, Satoko
    Matsuo, Junko
    Nagayama, Shinichi
    Fukuzaki, Koichiro
    Nagata, Ryoichi
    Kito, Go
    JOURNAL OF APPLIED TOXICOLOGY, 2007, 27 (01) : 78 - 85
  • [7] Extracellular pH modifies drug blockade on the human ether-a-go-go related gene (HERG) channels
    Lin, CG
    Cvetanovic, I
    Ranade, V
    Somberg, JC
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (05) : 122A - 122A
  • [8] Common pharmacophores for uncharged human ether-a-go-go-related gene (hERG) blockers
    Aronov, Alex M.
    JOURNAL OF MEDICINAL CHEMISTRY, 2006, 49 (23) : 6917 - 6921
  • [9] Development of a high-throughput electrophysiological assay for the human ether-a-go-go related potassium channel hERG
    Gillie, Daniel J.
    Novick, Steven J.
    Donovan, Brian T.
    Payne, Lisa A.
    Townsend, Claire
    JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS, 2013, 67 (01) : 33 - 44
  • [10] Effect of β-adrenoceptor blockers on Human Ether-a-go-go-Related gene (HERG) potassium channels
    Dupuis, DS
    Klaerke, DA
    Olesen, SP
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2005, 96 (02) : 123 - 130